Premium
Translokin (Cep57) Interacts with Cyclin D1 and Prevents Its Nuclear Accumulation in Quiescent Fibroblasts
Author(s) -
RuizMiró Maria,
Colomieus,
Fernández Rita M.H.,
Garí Eloi,
Gallego Carme,
Aldea Martí
Publication year - 2011
Publication title -
traffic
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.677
H-Index - 130
eISSN - 1600-0854
pISSN - 1398-9219
DOI - 10.1111/j.1600-0854.2011.01176.x
Subject(s) - cyclin d1 , microbiology and biotechnology , biology , cyclin d , cyclin a , cyclin , cyclin b , cyclin a2 , cell cycle , cancer research , cyclin dependent kinase complex , cell , biochemistry
Nuclear accumulation of cyclin D1 because of altered trafficking or degradation is thought to contribute directly to neoplastic transformation and growth. Mechanisms of cyclin D1 localization in S phase have been studied in detail, but its control during exit from the cell cycle and quiescence is poorly understood. Here we report that translokin (Tlk), a microtubule‐associated protein also termed Cep57, interacts with cyclin D1 and controls its nucleocytoplasmic distribution in quiescent cells. Tlk binds to regions of cyclin D1 also involved in binding to cyclin‐dependent kinase 4 (Cdk4), and a fraction of cyclin D1 associates to the juxtanuclear Tlk network in the cell. Downregulation of Tlk levels results in undue nuclear accumulation of cyclin D1 and increased Cdk4‐dependent phosphorylation of pRB under quiescence conditions. In turn, overexpression of Tlk prevents proper cyclin D1 accumulation in the nucleus of proliferating cells in an interaction‐dependent manner, inhibits Cdk4‐dependent phosphorylation of pRB and hinders cell cycle progression to S phase. We propose that the Tlk acts as a key negative regulator in the pathway that drives nuclear import of cyclin D1, thus contributing to prevent pRB inactivation and to maintain cellular quiescence.